New Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and Patients
An insider's guide to the FDA's new drug approval process, this book explains the essential steps for scientists, investors, and patients. It breaks down the regulatory hurdles and opportunities in drug development, offering clear insights into the path from innovation to market availability.
About This Book
This book offers an insider's perspective on the FDA's new drug approval process, tailored for scientists, investors, and patients seeking to understand the regulatory landscape.
It provides practical insights into the steps involved in bringing new drugs to market, highlighting key considerations for each audience.
Written by Lawrence T. Friedhoff, the guide aims to clarify the complexities of drug development and approval without overwhelming technical jargon.
Ideal for those involved in pharmaceuticals or interested in healthcare innovation, it serves as a valuable resource for informed decision-making.
Reviews
No reviews yet. Be the first to review this book!